Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Readmission After Gynecologic Oncology Surgery

Gynecol Oncol; ePub 2016 Feb 27; Uppal, Penn, et al

Reducing surgical site infections (SSIs) can help reduce hospital readmission rates following major gynecologic oncology surgery, as can identifying patients at a high risk of readmission. This according to a cohort study that examined the association between risk factors with respect to 30-day unplanned readmission after major surgery for a gynecologic malignancy. Researchers found:

• Readmission rate was 6.5%.

• Independent predictors of readmission included operative time ≥3 hours (OR=1.39), open abdominal surgery (OR=2.2), any complication prior to discharge (OR=1.6), 2 or more additional surgical procedures (OR=1.34), or cervical cancer as the site of primary disease (OR=1.30).

• Infections were a cause of 45% of readmissions, with SSIs accounting for 29.2% of all readmissions.

• 75% of readmissions occurred within 2 weeks of discharge.

Citation: Uppal S, Penn C, del Carmen MG, Rauh-Hain JA, Reynolds RK, Rice LW. Readmissions after major gynecologic oncology surgery. [Published online ahead of print February 27, 2016]. Gynecol Oncol. doi:http://dx.doi.org/10.1016/j.ygyno.2016.02.031.